1.Relationship between Apoptosis Promoting Effector Molecule TFAR1 9 and Uterine Myoma
Journal of Modern Laboratory Medicine 2016;31(5):94-96
Objective To examine serum TFAR19 activity in uterine myoma patients.Methods 45 of operation patients with uterine myoma in Beijing Huairou Maternal and Child Health Hospital were recruited.Among them,diameter of maximal myoma from 6 to 10 centineters were 29 (group A),diameter of maximal myoma more than 10 centineters were 16 (group B).In addition,25 unrelated healthy women of childbearing age from physical examination center were enrolled as controls (group C),all of the peripheral venous blood was collected after admission.Enzyme-linked immunosorbent assay (ELISA) was used to examine serum TFAR1 9 activity in uterine myoma patients.Results The activity of TFAR1 9 in group A,group B and group C were 25.32±1.93,14.41±2.28 and 34.79±4.65 respectively.The TFAR19 activity in each group was sta-tistically significant difference (F=7.93,P=0.01).Compared with group C,the TFAR19 activity in group B (q=5.606,P<0.001),group A (q=3.055,P=0.034)was statistically significant difference.The TFAR19 activity in uterine myoma patients subgroups (group A,group B)was statistically significant difference (q=3.086,P=0.033).Age between each groups was not statistically significant difference (F=2.086,P=0.132).Conclusion The decrease of TFAR19 can inhibit apoptosis.Participating the occurrence of uterine myoma,it is connected with diameter of myoma.The larger diameter of my-oma,the lower TFAR1 9 activity of examination will be.
2.Quality standard for Yushangling Capsule
Ping WU ; Qiuming RU ; Chunshi LI
Chinese Traditional Patent Medicine 1992;0(02):-
AIM: To establish the quality standard for Yushangling Capsule(Angelica Sinensis,Borneolum Syntheticum,Radix et Rhizoma Notoginseng,etc.). METHODS: Angelica Sinensis and Borneolum Syntheticum were identified by TLC,and the contents of effective components were determined by HPLC. RESULTS: Angelica sinensis,and Borneolum Syntheticum could be identified by TLC.The linear ranges of notoginsenoside R_1,ginsenoside Rg_1 and Rb_1 were 0.104 6-1.987 4 ?g,0.407 6-7.744 4 ?g,0.414 8-7.881 2 ?g,respectively,the average recoveries were 99.7%(RSD=0.6%),99.5%(RSD=0.5%),100.1%(RSD=0.7%),respectively CONCLUSION: The method is simple,accurate and high specificity with good repeatability and can be used for quality control of Yushangling Capsule.
3.Study on Quality Standard for Fushenning Tablets
Qiuming RU ; Chunshi LI ; Ping WU
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-
Objective To establish the quality standard for Fushenning Tablets. Methods Radix et Rhizoma Rhei,Fructus Gardeniae,Rhizoma Anemarrhenae,Radix Stephaniae Tetrandrae were identified by TLC,and the content of berberine hydrochloride of Cortex Phellodendri Chinensis was determined by HPLC. Results TLC could identify Radix et Rhizoma Rhei,Fructus Gardeniae,Rhizoma Anemarrhenae,Radix Stephaniae Tetrandrae effectively. Berberine Hydrochloride showed a good linear relationship in the range of 0.021 42~ 0.110 20 ? g. The average recovery was 100.6 %(n=6) and RSD was1.4 % . Conclusion This method is simple,accurate,specific and reproducible,and can be used for quality control of Fushenning Tablets.
4.Determination of Acetamidopyrrolidone in Compound Huonaosu Capsules by RP-HPLC
Chunxiang ZHAO ; Zhuosong JIANG ; Chunshi LI ; Qiuming RU ; Guijie ZHANG ; Lianxiu ZHENG ;
Chinese Traditional Patent Medicine 1992;0(08):-
Objective: To establish the determination method of acetamidopyrrolidone in Compound Huonaosu Capsules with RP HPLC. Methods: Kromasil C 18 column was used. The mobile phase was methanol water(10∶90) with 0.6ml?min -1 of flow rate, and the detection wavelength was at 230nm. Results: The linear range of acetamidopyrrolidone concentration was from 0.17 to 0.78mg?ml -1 and correlation coefficient was 0.9995. The average recovery of sample was 99.9% and RSD and 0.62%(n=5). Conclusion: The method is simple, accurate and reproducible. It can be used for determination of acetamidopyrrolidone Compound in Huonaosu Capsules.